Indrapr.Medical

INDRAPRASTHAMEDICALCORPORATION02 May 2024

Healthcare

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Indrapr.Medical

Indrapr.Medical

Healthcare

INDRAPRASTHAMEDICALCORPORATION02 May 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
23-May-2023	D	This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23.	15-Sep-2023
20-May-2022	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2022, inter alia, has recommended a dividend @25% i.e. Rs. 2.50 per share for the financial year 2021-22.	15-Sep-2022
08-May-2019	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2019, inter alia, has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share for the financial year 2018-19. Dividend if approved by shareholders will be paid on or before 30th October, 2019.	12-Sep-2019
09-May-2018	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2018, inter alia, have recommended a dividend @ 15% (Rs 1.50/- per share) for the financial year 2017-18.	12-Sep-2018
26-May-2017	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2017, has recommended the payment of dividend @18% i.e. Rs. 1.80 per share for the financial year 2016-17.	14-Sep-2017
20-May-2016	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2016, inter alia, has recommended the payment of dividend @ 18% i.e. (Rs. 1.80 per share) for the financial year 2015-16.	18-Aug-2016
26-May-2015	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2015, inter alia, have recommended the payment of dividend @ 18% i.e. Rs. 1.80 per share for the financial year 2014-15.	16-Sep-2015
23-May-2014	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2014, inter alia, have recommended a dividend @ 18% (Rs. 1.80 per share) for the financial year 2013-14.	18-Sep-2014
08-May-2013	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2013, have recommended the payment of dividend @ 16% i.e.Rs. 1.60 per share for the financial year 2012-13.	19-Sep-2013
24-May-2012	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2012, inter alia, have approved the accounts and recommended the payment of dividend @ 16% i.e. Rs 1.60 per share for the financial year 2011-12.	06-Sep-2012
12-May-2011	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2011, inter alia, has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share for the financial year 2010-11.	05-Sep-2011
27-Apr-2010	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2010, inter alia, has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share for the financial year 2009-10.	30-Aug-2010
30-Apr-2009	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2009, inter alia, has recommended the payment of dividend @ 15% i.e. Rs 1.50 per share for the financial year 2008-09.	27-Aug-2009
10-Jun-2008	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 09, 2008, inter alia, has recommended a dividend @ 14% (Rs 1.40 per share) for the Financial Year 2007-2008.	28-Aug-2008
29-May-2007	D	Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2007, inter alia, has recommended the payment of dividend @ 12.5% i.e. Rs 1.25 per share for the financial year 2006-07.	07-Sep-2007
23-May-2005	D	10% Dividend	18-Aug-2005
22-Mar-2024	BC	we hereby enclose a copy of the Postal Ballot Notice for seeking Approval of its members by way of Postal Ballot voting (only through E-voting) for the businesses as set out in the Postal Ballot noti	24-Apr-2024
06-Feb-2024	BC	This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 6th February, 2024 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-a	01-Apr-2024
01-Apr-2024	BC	We hereby inform you that Mr. S Regunathan (DIN 00286505), Mr. Deepak Vaidya (DIN 00337276) and Mr. Satnam Arora (DIN 00010667) have completed their tenure viz. second term of 5 consecutive years on	31-Mar-2024
01-Apr-2024	BC	This is to inform you that Mr. Vikram Bhat (DIN 09076418) has tendered his resignation (vide email dated 28th March, 2024) as Non- Executive Director (Nominee Director- Govt. of NCT of Delhi- Promote	28-Mar-2024
05-Mar-2024	BC	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2024 inter alia to consider and approve the appointment of an Independen	07-Mar-2024

Announcement Date23-May-2023

Ex Dividend Date15-Sep-2023

Dividend(%)30

Announcement Date20-May-2022

Ex Dividend Date15-Sep-2022

Dividend(%)25

Announcement Date08-May-2019

Ex Dividend Date12-Sep-2019

Dividend(%)16

Announcement Date09-May-2018

Ex Dividend Date12-Sep-2018

Dividend(%)15

Announcement Date26-May-2017

Ex Dividend Date14-Sep-2017

Dividend(%)18

Announcement Date20-May-2016

Ex Dividend Date18-Aug-2016

Dividend(%)18

Announcement Date26-May-2015

Ex Dividend Date16-Sep-2015

Dividend(%)18

Announcement Date23-May-2014

Ex Dividend Date18-Sep-2014

Dividend(%)18

Announcement Date08-May-2013

Ex Dividend Date19-Sep-2013

Dividend(%)16

Announcement Date24-May-2012

Ex Dividend Date06-Sep-2012

Dividend(%)16

Announcement Date12-May-2011

Ex Dividend Date05-Sep-2011

Dividend(%)16

Announcement Date27-Apr-2010

Ex Dividend Date30-Aug-2010

Dividend(%)16

Announcement Date30-Apr-2009

Ex Dividend Date27-Aug-2009

Dividend(%)15

Announcement Date10-Jun-2008

Ex Dividend Date28-Aug-2008

Dividend(%)14

Announcement Date29-May-2007

Ex Dividend Date07-Sep-2007

Dividend(%)12

Announcement Date23-May-2005

Ex Dividend Date18-Aug-2005

Dividend(%)10

No Rights has been declared by INDRAPRASTHAMEDICALCORPORATION

Book Closure

Record Date	Split Date	Purpose
24-Apr-2024	01 Jan'1900	we hereby enclose a copy of the Postal Ballot Notice for seeking Approval of its members by way of Postal Ballot voting (only through E-voting) for the businesses as set out in the Postal Ballot noti
01-Apr-2024	-	This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 6th February, 2024 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-a
31-Mar-2024	-	We hereby inform you that Mr. S Regunathan (DIN 00286505), Mr. Deepak Vaidya (DIN 00337276) and Mr. Satnam Arora (DIN 00010667) have completed their tenure viz. second term of 5 consecutive years on
28-Mar-2024	-	This is to inform you that Mr. Vikram Bhat (DIN 09076418) has tendered his resignation (vide email dated 28th March, 2024) as Non- Executive Director (Nominee Director- Govt. of NCT of Delhi- Promote
07-Mar-2024	-	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2024 inter alia to consider and approve the appointment of an Independen

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Indraprastha Medical Corporation Ltd ₹267.55(0.00/0.00%)	267.55	+0.00	2,452.63	215.51	21.75	5.91
Shalby Ltd ₹278.70(+1.40/0.50%)	278.70	+1.40	2,995.11	92.44	30.08	2.95
Fortis Healthcare Ltd ₹440.90(+2.35/0.54%)	440.90	+2.35	33,108.69	68.22	433.86	3.68
Poly Medicure Ltd ₹1,648.40(+5.20/0.32%)	1,648.40	+5.20	15,770.02	66.99	65.98	11.88
Aster DM Healthcare Ltd ₹348.20(+0.05/0.01%)	348.20	+0.05	17,390.55	40.87	80.32	5.37
GPT Healthcare Ltd ₹172.25(0.00/0.00%)	172.25	+0.00	1,413.39	0.00	28.97	6.63

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	306.46	317.00	306.51	274.05	276.93	284.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	306.46	317.00	306.51	274.05	276.93	284.37
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	4.27	4.17	3.56	4.79	3.08	1.39
Total Income	310.73	321.17	310.07	278.84	280.01	285.76
Total Expenditure	259.16	266.64	259.25	240.91	239.87	240.77
PBIDT	51.57	54.53	50.82	37.93	40.14	44.99
Interest	0.87	0.85	0.78	0.87	0.87	1.39
PBDT	50.70	53.68	50.04	37.06	39.27	43.60
Depreciation	10.03	10.03	9.81	9.86	9.86	9.85
Tax	11.68	11.27	10.91	3.27	9.97	10.63
Deferred Tax	-0.45	-0.47	-1.18	4.09	-1.46	-2.01
Reported Profit After Tax	29.44	32.85	30.50	19.84	20.90	25.13
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	29.44	32.85	30.50	19.84	20.90	25.13

EPS (Unit Curr.)	3.21	3.58	3.33	2.16	2.28	2.74
EPS (Adj) (Unit Curr.)	3.21	3.58	3.33	2.16	2.28	2.74
Calculated EPS (Unit Curr.)	3.21	3.58	3.33	2.16	2.28	2.74
Calculated EPS (Adj) (Unit Curr.)	3.21	3.58	3.33	2.16	2.28	2.74
Calculated EPS (Ann.) (Unit Curr.)	12.85	14.33	13.31	8.66	9.12	10.97
Calculated EPS (Adj) (Ann.) (Unit Curr.)	12.85	14.33	13.31	8.66	9.12	10.97
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	91.67	91.67	91.67	91.67	91.67	91.67
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	16.83	17.20	16.58	13.84	14.49	15.82
PBDTM(%)	16.54	16.93	16.33	13.52	14.18	15.33
PATM(%)	9.61	10.36	9.95	7.24	7.55	8.84

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	91.67	91.67	91.67	91.67	91.67	91.67
Reserves Total	287.78	233.77	181.08	176.13	152.36	140.64
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	379.45	325.44	272.75	267.80	244.03	232.31
Secured Loans	0.00	0.00	0.00	3.98	21.29	45.56
Unsecured Loans	2.48	5.31	2.51	0.00	0.00	20.00
Total Debt	2.48	5.31	2.51	3.98	21.29	65.56
Total Liabilities	381.93	330.75	275.26	271.78	265.32	297.87
APPLICATION OF FUNDS :
Gross Block	497.80	468.85	455.30	448.38	396.70	387.93
Less : Accumulated Depreciation	222.75	191.99	171.97	145.71	116.60	93.96
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	275.05	276.86	283.33	302.67	280.10	293.97
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	2.53	0.00	3.33	0.00	1.26	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	8.45	9.99	8.74	12.07	8.32	9.12
Sundry Debtors	68.24	43.35	67.39	79.15	76.20	84.47
Cash and Bank	128.75	68.45	27.52	24.01	22.44	7.94
Loans and Advances	17.64	35.64	37.78	26.24	28.60	31.37
Total Current Assets	223.08	157.43	141.43	141.47	135.55	132.90
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	113.24	89.80	104.98	125.82	111.00	86.50
Provisions	13.91	0.87	8.41	9.81	6.81	7.37
Total Current Liabilities	127.15	90.67	113.39	135.63	117.80	93.87
Net Current Assets	95.93	66.76	28.04	5.84	17.75	39.03
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	6.31	4.85	6.96	6.61	11.75	10.15
Deferred Tax Liability	26.29	28.04	29.22	26.87	39.13	39.91
Net Deferred Tax	-19.98	-23.19	-22.26	-20.26	-27.38	-29.76
Total Assets	353.53	320.43	292.44	288.26	271.73	303.23
Contingent Liabilities	64.77	69.82	56.95	55.59	49.16	61.69

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	41.74	24.92	20.33	16.82	2.52
Net Cash from Operating Activities	144.47	94.30	26.81	86.45	75.19
Net Cash Used In Investing Activities	-107.91	-74.11	-19.08	-40.19	-16.70
Net Cash Used In Financing Activities	-26.04	-3.37	-3.14	-42.74	-44.18
Net Inc./Dec In Cash And Cash Equivalents	10.52	16.82	4.59	3.51	14.30
Cash And Cash Equivalents At End Of The Year	52.26	41.74	24.92	20.33	16.82

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

51.00%

FII Shareholding

1.08%

DII Shareholding

4.91%

Public Shareholding

43.01%

**Promoter pledged shareholding 51.00%

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Ltd is in the Healthcare sector, having a market capitalization of Rs. 2449.88 crores. It has reported a sales of Rs. 306.46 crores and a net profit of Rs. 29.44 crores for the quarter ended December 2018. The company management includes Jasmine Shah, Jasmine Shah,Prathap C Reddy,Suneeta Reddy,Sangita Reddy,Vineeta Rai,S Regunathan,Satnam Arora,Deepak Vaidya,Arun Rai,Vinayak Chatterjee,MADHUMITA GANGULI,Menaka Gurusswamy,Salil Singhal,Vikram Bhat,Mahesh Verma,P Shivakumar,Tejpreet S Chopra (Indraprastha Medical Corporation Ltd) among others.

Chairman

Jasmine Shah

Registered office

Sarita Vihar,Delhi-Mathura Road,New Delhi,New Delhi,110076

FAX :91-11-26823629

Background

Incorporation Year1988

Face Value₹10

Market Lot1

How to buy Indrapr.Medical shares on nse?

To buy Indrapr.Medical shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Indrapr.Medical share price today?

The Indrapr.Medical shares price on nse is Rs.267.55 today.

What is the market cap of Indrapr.Medical shares on NSE ?

The company has a market capitalization of Rs.2452.63Cr

What is the PE & PB ratio of Indrapr.Medical shares ?

PE is 21.75 and PB is 5.91

What is the 52 Week High and Low of Indrapr.Medical shares?

Indrapr.Medical stock price high: Rs.282.8 Indrapr.Medical stock price low: Rs.81.9